Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Iomab-B met the durable complete remission endpoint.

Manufacturing 59

Manufacturing Biopharma Pharmaceutical Pharma 59

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

MedCity News

JUNE 20, 2023

Arcellx attributes the death to limitations of the treatments that patients receive while their cell therapies are being manufactured. The company is working to expand these so-called bridging therapy options for patients.

Patients 89

Patients FDA Manufacturing Biopharma 89

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

Clarivate

JULY 24, 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. The post Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023 appeared first on Clarivate.

Pharma 52

Pharma Biopharma Prospecting Training 52

MedCity News

JULY 6, 2022

Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

Pharma 101

Pharma Consulting Patients Manufacturing 101

MedCity News

JANUARY 28, 2024

The big three insulin manufacturers have cut prices across their product lineups, but potential competition from other biosimilar insulins is still in earlier stages of development. Insulin prices have long been a pain point for diabetics.

Competition 97

Competition Patients Manufacturing Biopharma 97

Pharmaceutical Technology

JUNE 15, 2023

AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. Artificial intelligence (AI) has many implications for pharmaceutical companies, including on research, drug discovery and development, manufacturing and trials. Here are a few ways AI is used in pharma today.

Pharma 52

Pharma Management Networking Manufacturing 52

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This may best be achieved by large pharma companies, with their combined $200bn annual R&D budget, compared to smaller companies that are relying on external investment.

Biopharma 111

Biopharma Pharma Marketing Management 111

Pharmaceutical Technology

SEPTEMBER 13, 2022

The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

European Pharmaceutical Review

OCTOBER 4, 2023

Eli Lilly and Company has agreed to acquire the radiopharmaceutical firm POINT Biopharma Global for $1.4 It is being investigated for patients with metastatic castration-resistant prostate cancer (mCRPC) after progression on hormonal treatment. This will be payable once the deal has completed. The post Lilly agrees $1.4

Biopharma 97

Biopharma Medicine Leads Manufacturing 97

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. The impact could be huge for the biopharma industry.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Pharmaceutical Technology

OCTOBER 25, 2022

Ast ellas Pharma has announced plans to make a strategic investment to back the development of Taysha Gene Therapies’ adeno-associated virus (AAV) development programmes for Rett syndrome and giant axonal neuropathy (GAN). This would allow the companies to boost the development of new therapy options for Rett syndrome and GAN patients.

Biopharma 105

Biopharma Pharmaceutical Manufacturing Patients 105

PM360

SEPTEMBER 28, 2022

Now, as the President of Accord BioPharma , the U.S. Now that you’re responsible for launching biosimilars in today’s market, what are currently the biggest barriers or issues manufacturers and marketers face that impedes the success of their biosimilar products? But now the big pharma companies have also jumped into the game.

Competition 98

Competition Marketing Biopharma Manufacturing 98

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. Innovent Biologics, a domestic manufacturer, is currently evaluating its anti-diabetic and weight-loss GLP-1 drug, mazdutide, in a phase 3 trial in Mainland China, backed by Eli Lilly.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Director US Marketing and Patient Engagement, argenx US, Inc. Founder and CEO, ConcentricLife MARKETER OF THE YEAR Conor Fogarty, Marketing Director, Neuroimmunology Franchise, Genentech, Inc.

Education 122

Education Marketing Media Management 122

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Pharmaceutical Technology

NOVEMBER 4, 2022

Any reduced availability of medicines has a significant impact on patient care. As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The CMO solution.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

Pharmaceutical Technology

JULY 7, 2022

Cell and gene therapies are currently at the forefront of immunotherapy cancer research, and a few approved therapies are already making a difference to disease outcomes for patients. But getting these drugs to patients requires risky transportation, and safety and success hinges on reliable, temperature-controlled logistics.

Medicine 98

Medicine Transportation Manufacturing Biopharma 98

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Weiss has also made substantial efforts to give back to the community at large. Braun Medical, Inc.

Marketing 52

Marketing Education Media Healthcare 52

pharmaphorum

JANUARY 27, 2023

While global macroeconomic uncertainty continues to impact financing, the pharma industry has focused on UK biotechs to strengthen product pipelines. The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report – and, on the whole, the findings are not positive.

Pharma 52

Pharma Manufacturing Biopharma Medicine 52

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Director US Marketing and Patient Engagement, argenx US, Inc. Cardiology: Bradley A.

Education 52

Education Marketing Media Biopharma 52

European Pharmaceutical Review

NOVEMBER 23, 2023

On numerous occasions, he emphasised the importance of being aware of the key differences when applying PAT in the process development lab versus commercial manufacturing. He urged the industry to explore how the technology can be applied across the entire biopharma pipeline. A big challenge is navigating variability.

Manufacturing 67

Manufacturing Biopharma Training Pharma 67

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? This resulted in not only a mismatch in the required manufacturing scale but also a significant over capacity as well. Let’s talk about continuous biopharma manufacturing. What are the main challenges in this area in particular?

Manufacturing 78

Manufacturing Food and Drug Administration Biopharma Marketing 78

European Pharmaceutical Review

OCTOBER 11, 2022

CROs offer services such as drug protocol development, site and investigator selection, patient recruitment, data collection and management, monitoring and biostatistical analysis. billion to develop and manufacture one drug. Sustained benefits for the CRO includes being involved in the pharma company’s future development plans.

Management 80

Management Pharma Pharmaceutical Biopharma 80

pharmaphorum

SEPTEMBER 30, 2022

New manufacturers, such as EQRx, have been vocal in their desire to bring new PD-1/PD-L1 checkpoint inhibitors (e.g. Perhaps more interestingly, similar signals have also emerged from traditional biopharma heavyweights, such as Novartis and Lilly, which one would typically associate with more conservative approaches to pricing.

Consulting 82

Consulting Marketing Pharma Manufacturing 82

Clarivate

OCTOBER 25, 2023

The biggest impacts are likely to be felt by patients with PDPs that use coinsurance, which most plans do for specialty drugs. Impact for patients taking the diabetes drugs and blood thinners might be less noticeable since these drugs tend to receive coverage as preferred brand tiers with copays.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

APRIL 4, 2023

of NSCLC patients with exon 19 and 21 mutations develop resistance mutations at C797S. According to GlobalData’s Pharma Intelligence Centre, Tagrisso is forecasted to have global sales of $8.19 The biopharma aims to start the study as soon as the IND is cleared by the FDA. Up to 12.5% billion in 2029.

Food and Drug Administration 52

Food and Drug Administration Biopharma FDA Pharmaceutical 52

Clarivate

MARCH 14, 2024

1] To mitigate the potential presence of nitrosamine impurities in pharmaceuticals, manufacturers are now facing impending regulatory requirements in various markets – in the European Union, for example, they were obligated to submit reformulation strategies and mitigation plans in late 2022. [2].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

eMediWrite

JUNE 6, 2022

However, if you asked the same people who make such medicines, considerably fewer people would be able to respond with the right manufacturers’ company name. This, combined with the rise of technology in pharma, raises the question of whether it’s time for pharma businesses to reconsider their corporate branding approach.

Pharmaceutical 52

Pharmaceutical Pharma Marketing Medicine 52

Pharmaceutical Technology

MAY 24, 2023

Amgen develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. Whilst Abliva and Ambrx Biopharma stand in second and third positions, respectively. Merck 42 Unlock company profile C. Menarini Industrie Farmaceutiche Riunite.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Pharmacology 52

Clarivate

JULY 5, 2023

In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

European Pharmaceutical Review

DECEMBER 19, 2022

Furthermore, the joint statement cites examples of successful switch of biological medicines manufactured and commercialised by different companies, which is stated to have become “common in clinical practice”. Chris was named a ‘Rising Star’ in the 2022 Legal 500 Rankings for Life Sciences and Healthcare.

Medicine 52

Medicine Biopharma Safety Food 52

Pharma Marketing Network

JANUARY 12, 2023

Advancing medicine, advancing patient care, and advancing equity in our global workforce are shared values of this year’s honorees driving transformational change and impact,” said Wendy White, interim CEO and 2022 STAR, HBA. These experiences have empowered Christi to become a leading industry voice advocating fiercely for patients.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52